
Therapeutic Area | MeSH |
|---|---|
| skin and connective tissue diseases | D017437 |
Tradename | Proper name | Company | Number | Date | Products |
|---|---|---|---|---|---|
| Siliq | brodalumab | Bausch Health Companies | N-761032 RX | 2017-02-15 | 1 products |
Brand Name | Status | Last Update |
|---|---|---|
| siliq | Biologic Licensing Application | 2024-11-07 |
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| psoriasis | EFO_0000676 | D011565 | L40 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Psoriasis | D011565 | EFO_0000676 | L40 | — | — | 1 | 4 | 1 | 6 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | — | — | — | — | 1 | 1 |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
| Drug common name | Brodalumab |
| INN | brodalumab |
| Description | Brodalumab (human mab) |
| Classification | Antibody |
| Drug class | monoclonal antibodies |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL1742996 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB11776 |
| UNII ID | 6ZA31Y954Z (ChemIDplus, GSRS) |



